发布时间：2024-04-24 13:55 Ad hoc announcement pursuant to Art. 53 LR

ZUG, Switzerland--(BUSINESS WIRE)--Galderma Group AG (SWX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2024.


Record net sales of 1.071 billion USD in the first quarter of 2024, surpassing for the first time the 1 billion USD mark for the first three months in a year

Net sales growth for the first quarter of 2024 was 12.4% year-on-year on a constant currency basis1, primarily driven by volume

Broad-based growth across all product categories, with constant currency year-on-year growth of 19.3% for Injectable Aesthetics, 8.4% for Dermatological Skincare, and 4.1% for Therapeutic Dermatology

Growth across geographies,especially in International markets while U.S. growth accelerated year-on-year

2024 full year guidance confirmed:7-10% net sales year-on-year growth at constant currency and Core EBITDA ma
=*=*=*=*=*=
当前为第1/18页
下一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页